Main Article Content
Meibomian gland dysfunction (MGD), has been well established as a major etiologic factor in dry eye disease, replacing long regarded aqueous deficiency. Lemp, et al reported that 86% of a dry eye clinic cohort demonstrated evidence of MGD.1 An understanding of normal meibomian gland function is important to effective dry eye management.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.
2. Wilcox MDA, et al. TFOS DEWS II – Tear Film Report – Ocular Surf 2017;(3):366–403.
3. Geerling G, Tauber J, Baudain C, et al. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52(4):2050–64.
4. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Corneal 2008;27 (10):1142–47.
5. Eitas R, et al. The rapid effect of pulsed eye laser on demodex density of facial skin. J Cosmet Laser Ther 2019;21(3):123–26.